Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor

被引:122
|
作者
Mirzabekov, T
Bannert, N
Farzan, M
Hofmann, W
Kolchinsky, P
Wu, LJ
Wyatt, R
Sodroski, J
机构
[1] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
[4] Leukosite Inc, Cambridge, MA 02142 USA
关键词
D O I
10.1074/jbc.274.40.28745
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Seven-transmembrane segment, G protein-coupled receptors (GPCRs) play important roles in many biological processes in which pharmaceutical intervention may be useful. High level expression and native purification of GPCRs are important steps in the biochemical and structural characterization of these molecules. Here, we describe enhanced mammalian cell expression and purification of a codon-optimized variant of the chemokine receptor CCR5, a GPCR that plays a central role in the entry of the human immunodeficiency virus-1 (HIV-1) into immune cells. CCR5 could be solubilized in its native state as determined by its ability to be precipitated by 2D7, a conformation-dependent anti-CCR5 antibody, and by the HIV-1 gp120 envelope glycoprotein. The 2D7 antibody recognized immature and mature forms of CCR5 equally, whereas gp120 preferentially recognized the mature form, a result that underscores a role for posttranslational modification of CCR5 in its HIV-1 coreceptor function. The methods described herein contribute to the analysis of CCR5 and are likely to be applicable to many other GPCRs.
引用
收藏
页码:28745 / 28750
页数:6
相关论文
共 50 条
  • [41] HIV-1 isolates resistant to CCR5 antagonists demonstrate increased affinity for the drug-bound coreceptor
    Buontempo, P. J.
    Wojcik, L.
    Buontempo, C.
    Strizki, J.
    Ralston, R.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S135 - S135
  • [42] Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies
    Weichseldorfer, Matthew
    Tagaya, Yutaka
    Reitz, Marvin
    DeVico, Anthony L.
    Latinovic, Olga S.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [43] Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains
    Lu, ZH
    Berson, JF
    Chen, YH
    Turner, JD
    Zhang, TY
    Sharron, M
    Jenks, MH
    Wang, ZX
    Kim, J
    Rucker, J
    Hoxie, JA
    Peiper, SC
    Doms, RW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) : 6426 - 6431
  • [44] High-Affinity Binding of Chemokine Analogs that Display Ligand Bias at the HIV-1 Coreceptor CCR5
    Rico, Carlos A.
    Berchiche, Yamina A.
    Horioka, Mizuho
    Peeler, Jennifer C.
    Lorenzen, Emily
    Tian, He
    Kazmi, Manija A.
    Fuerstenberg, Alexandre
    Gaertner, Hubert
    Hartley, Oliver
    Sakmar, Thomas P.
    Hubert, Thomas
    BIOPHYSICAL JOURNAL, 2019, 117 (05) : 903 - 919
  • [45] Theoretical Studies on the Interactions and Interferences of HIV-1 Glycoprotein gp120 and Its Coreceptor CCR5
    Da, Lin-tai
    Wu, Yun-Dong
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (02) : 359 - 369
  • [46] HIV-1 isolates resistant to CCR5 antagonists demonstrate increased affinity for the drug-bound coreceptor
    Buontempo, P. J.
    Wojcik, L.
    Buontempo, C.
    Strizki, J.
    Ralston, R.
    ANTIVIRAL THERAPY, 2007, 12 : S135 - S135
  • [47] CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
    Oh, Djin-Ye
    Jessen, Heiko
    Kuecherer, Claudia
    Neumann, Konrad
    Oh, Nari
    Poggensee, Gabriele
    Bartmeyer, Barbara
    Jessen, Arne
    Pruss, Axel
    Schumann, Ralf R.
    Hamouda, Osamah
    PLOS ONE, 2008, 3 (07):
  • [48] Variation of CCR5AS lncRNA Enhances HIV-1 Infection Through Regulation of CCR5 Expression
    Zou, Sen
    VIRAL IMMUNOLOGY, 2020, 33 (08) : 536 - 538
  • [49] High level expression, purification and characterization of recombinant CCR5 as a vaccine candidate against HIV
    Wu, Kongtian
    Xue, Xiaochang
    Li, Meng
    Qin, Xin
    Zhang, Cun
    Li, Weina
    Hao, Qiang
    Wang, Zenglu
    Liu, Qian
    Zhang, Wei
    Zhang, Yingqi
    PROTEIN EXPRESSION AND PURIFICATION, 2013, 89 (02) : 124 - 130
  • [50] CCR5 antagonist-resistant HIV-1 entry kinetics as a function of CD4 and CCR5 surface expression
    Putcharoen, O.
    Lee, S-H
    Henrich, T. J.
    Vanichanan, J.
    Kuritzkes, D. R.
    Tsibris, A. M. N.
    ANTIVIRAL THERAPY, 2011, 16 : A64 - A64